NCT00319306已完成3 期
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 550
- 试验地点
- 59
- 主要终点
- In a real life setting, to compare Symbicort® Single Inhaler Therapy with a patient's previous therapy (including low dose ICS), by assessment of the changes in the Asthma Control Questionnaire score in uncontrolled asthmatic patients.
研究概览
简要总结
The purpose of this study is to determine whether patients with asthma are better able to manage and control their symptoms by using one inhaler daily that both prevents as well as treats the symptoms of an asthma exacerbation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged over 18
- •Confirmed diagnosis of mild to moderate asthma by doctor
- •Currently receiving inhaled corticoid-steroid medicine for treatment of asthma and requiring a review of current asthma treatment
排除标准
- •Women who are pregnant, breast-feeding, or planning pregnancy
- •Patients with a history of chronic obstructive pulmonary disease
- •Patients using any beta blocker therapy
- •Patients receiving steroid tablets or steroid injections
结局指标
主要结局
In a real life setting, to compare Symbicort® Single Inhaler Therapy with a patient's previous therapy (including low dose ICS), by assessment of the changes in the Asthma Control Questionnaire score in uncontrolled asthmatic patients.
次要结局
- Change in forced expiratory volume in one second (FEV1)
- Change in peak expiratory flow (PEF)
- Patient Reported Outcomes: AQLQ(S), SATQ, RCP-3 scores
研究者
研究点 (59)
Loading locations...
相似试验
进行中（未招募）
1 期
Real life effectiveness in asthma of Symbicort® Single Inhaler Therapy (RELEASE) - RELEASEThis is a Phase IIIb Trial to be conducted in adult, uncontrolled asthmatic patients.Classification code 10003553EUCTR2005-000372-41-GBAstraZeneca UK Limited
已完成
3 期
A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®AsthmaNCT00244608AstraZeneca100
已完成
不适用
Device Mixing in Asthma, a General Practice Research Database StudyAsthmaNCT01313585Research in Real-Life Ltd815,377
已完成
不适用
A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mobile Device Compared With Usual Asthma Care to Treat 6-17 Year Old PatientsAsthma in ChildrenNCT06062433Mayo Clinic49
已完成
不适用
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMARTModerate/Severe AsthmaNCT00785733AstraZeneca1,182